Ascendiant Capital Markets Boosts Atossa Therapeutics (NASDAQ:ATOS) Price Target to $7.50
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) had its target price hoisted by Ascendiant Capital Markets from $7.25 to $7.50 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. ATOS has been the topic of a number of other research reports. HC Wainwright reissued a “buy” […]
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) had its target price hoisted by Ascendiant Capital Markets from $7.25 to $7.50 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. ATOS has been the topic of a number of other research reports. HC Wainwright reissued a “buy” […]
